Status:
TERMINATED
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Intraventricular Hemorrhage
Autoregulation
Eligibility:
All Genders
1-7 years
Phase:
NA
Brief Summary
Annually, almost 5,000 extremely low birth weight (9 ounces to about 2 lbs) infants born in the US survive with severe bleeding in the brain (intraventricular hemorrhage); this devastating complicatio...
Eligibility Criteria
Inclusion
- ventilated ELBW (401-1000 grams) infants
- 23 to 30 weeks' gestation
- umbilical arterial catheter placed during newborn resuscitation
Exclusion
- presence of complex congenital anomalies or chromosomal abnormality
- presence of central nervous system malformation
- infants with hydrops fetalis
- infants in extremis
- infants with early (\<3 hour of age) intraventricular hemorrhage
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00665769
Start Date
June 1 2008
End Date
November 1 2015
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Children's Hospital
Houston, Texas, United States, 77030